Systemische Psoriasistherapie – der nächste Schritt: Adalimumab

Author： Wozel G.   Sticherling M.  

Publisher： Springer Publishing Company

ISSN： 0017-8470

Source： Der Hautarzt, Vol.58, Iss.6, 2007-06, pp. : 515-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Systemische Therapie der Rosazea

By Schaller M.   Belge K.  

Der Hautarzt, Vol. 64, Iss. 7, 2013-07 ,pp. : 500-505

Springer Publishing Company

Access to resources Recommend Favorite

Adalimumab Treatment for SAPHO Syndrome

By Arias-Santiago Salvador   Sanchez-Cano Daniel   Callejas-Rubio José Luis   Fernández-Pugnaire María Antonia   Ortego-Centeno Norberto  

Acta Dermato-Venereologica, Vol. 90, Iss. 3, 2010-05 ,pp. : 301-302

Medical Journals Limited

Access to resources Recommend Favorite

Hyperpigmentation of the Face Following Adalimumab Treatment

By Blomberg Maria   Zachariae Claus   Grønhøj Frederik  

Acta Dermato-Venereologica, Vol. 89, Iss. 5, 2009-09 ,pp. : 546-547

Medical Journals Limited

Access to resources Recommend Favorite

Successful Treatment of Lichen Planus with Adalimumab

By Holló Peter   Szakonyi Jozsef   Kiss Dorottya   Jokai Hajnalka   Horváth Attila   Kárpáti Sarolta  

Acta Dermato-Venereologica, Vol. 92, Iss. 4, 2012-07 ,pp. : 385-386

Medical Journals Limited

Access to resources Recommend Favorite

Adalimumab (HumiraTM): a brief review for dermatologists

By Scheinfeld N  

Journal of Dermatological Treatment, Vol. 15, Iss. 6, 2004-12 ,pp. : 348-352

Informa Healthcare

Access to resources Recommend Favorite